About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 77 record(s)
Req # A-2021-000029
How many accidents related to ceiling lifts have been reported in Canada since 2001? Of these, how many accidents refer to a return-to-charge feature? Has there been legislation in place since about 2005 in Western Canada to prohibit the sale of patient lifts with such a feature? How many accidents have been reported due to a lack of equipment maintenance? How many accidents have been reported with Arjo, Arjohuntleigh, or BHM Medical equipment?Organization: Health Canada
May 2021
Req # A-2021-000076
Summary of the number of adverse reaction reports for vaccine products per year from January 1, 2020 to May 1, 2021, domestic reports only.Organization: Health Canada
May 2021
Req # A-2019-001895
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02428041, 000725512, E2B_02415074, E2B_02406573, E2B_02406900, E2B_00945105, E2B_02407763, E2B_02417349, E2B_02417360, E2B_02277106, E2B_02036323, E2B_02414972, E2B_02420825, E2B_02420839, E2B_02420846.Organization: Health Canada
May 2021
Req # A-2020-000926
Adverse Reaction Reports (AERs). Report numbers: E2B_02814632, E2B_02499388 , E2B_02742861.Organization: Health Canada
May 2021
Req # A-2020-001119
Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_03107034.Organization: Health Canada
May 2021
Req # A-2020-001286
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-121932-853, Public Health Agency of Canada Metrics and Approaches Under Staffing Modernization.Organization: Health Canada
May 2021
Req # A-2020-001599
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03352506.Organization: Health Canada
May 2021
Req # A-2020-001652
Adverse Reaction Reports (AERs) for GLYCERYL TRINITRATE. Report numbers: E2B_03193921, E2B_03172074, E2B_03172067.Organization: Health Canada
May 2021
Req # A-2020-001675
Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_01198405.Organization: Health Canada
May 2021
Req # A-2020-001676
Adverse Drug Reaction (ADR) for PETHIDINE HYDROCHLORIDE. Report number: E2B_01198405.Organization: Health Canada
May 2021